4.5 Article

MiR-214 reduces cell survival and enhances cisplatin-induced cytotoxicity via down-regulation of Bcl2l2 in cervical cancer cells

Journal

FEBS LETTERS
Volume 587, Issue 5, Pages 488-495

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.febslet.2013.01.016

Keywords

miRNA; miR-214; Bcl2l2; Cell survival; Apoptosis; Cervical cancer

Funding

  1. National Natural Science Foundation of China [30873017, 91029714, 31071191, 31270818]
  2. Natural Science Foundation of Tianjin [08JCZDJC23300, 09JCZDJC17500, 12JCZDJC25100]

Ask authors/readers for more resources

MiR-214 has been shown to inhibit cell growth, migration and invasion. Here we demonstrate that ectopic expression of miR-214 reduces cell survival, induces apoptosis and enhances sensitivity to cisplatin through directly inhibiting Bcl2l2 expression in cervical cancer HeLa and C-33A cells. Further analysis reveals that apoptosis induced by miR-214 is correlated with increased expression of Bax, caspase-9, caspase-8 and caspase-3. Moreover, we show that miR-214 is regulated by DNA methylation and histone deacetylation. Taken together, these data suggest that miR-214 might be a candidate target for the development of novel therapeutic strategies to treat cervical cancer. (C) 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available